Europe — EMA

Orebriton (Ticagrelor)

Request sourcing

Pack/s

What is Ticagrelor?

Ticagrelor, the active ingredient in Orebriton, is a P2Y12 receptor antagonist presented as a unknown/unknown for oral use. It treats and reduces the risk of thrombotic cardiovascular events in patients with acute coronary syndrome. GNH USA supplies Orebriton as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Orebriton as a licensed, GDP‑compliant international pharmaceutical supplier serving ...

What is Ticagrelor used for?

Orebriton (ticagrelor) is the ...

What are the side effects of Ticagrelor?

Common ...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →